Clinical Trial Update: Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating the combination of epoetin beta and all-trans retinoic acid for anemia in myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• epoetin beta (epoetin beta)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: Anemia in Myelodysplastic Syndromes | Phase 2 | Status: UNKNOWN